Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Simcere Pharmaceutical Group (2096 HK)
Watchlist
58
Analysis
Health Care
•
China
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
12 Jan 2025 07:30
APAC Healthcare Weekly (Jan 12)- Wuxi Biologics, Astellas, Otsuka, Samsung Biologics, Pharmaessentia
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
Tina Banerjee
Follow
495 Views
Share
bullish
•
Quantitative Analysis
•
08 Dec 2024 10:05
Hong Kong Connect Flows (Dec 6th): Alibaba, CCB, Sunny Optical, Xpeng, CMB
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, CCB, Sunny Optical, Xpeng, CMB.
Ke Yan, CFA, FRM
Follow
605 Views
Share
bearish
•
Keymed Biosciences
•
22 Sep 2024 09:43
China Healthcare Weekly (Sep.22) - CR Sanjiu's Trouble, Weight-Loss Drug Market Saturation, Keymed
Anhui's VBP includes OTC TCM, challenging CR Sanjiu's pricing autonomy. There are concerns about weight-loss drug market saturation. CM310 missing...
Xinyao (Criss) Wang
Follow
403 Views
Share
bullish
•
Cross Asset Strategy
•
15 Aug 2024 16:38
Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 15)
Successful returns in Hong Kong has meant getting the industry right! Lygend benefits from moratorium on new nickel mine permits. Sino Bio RX...
David Mudd
Follow
228 Views
Share
bullish
•
Chongqing Taiji Industry (Group) A
•
04 Aug 2024 11:00
China Healthcare Weekly (Aug.4)- Taiji Group & China TCM, TCM Formula Granules VBP, Keymed's Trouble
Substitution of TCM formula granules for decoction pieces is a trend despite the VBP. Keymed will face difficulties without NRDL negotiation....
Xinyao (Criss) Wang
Follow
329 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.46.12
x